The LEARN Study for CVD Prevention (NCT05242952) | Clinical Trial Compass
CompletedNot Applicable
The LEARN Study for CVD Prevention
United States78 participantsStarted 2023-05-10
Plain-language summary
The investigator is testing a virtual environment to address prevention of HIV-related comorbidities.
Who can participate
Age range30 Years – 65 Years
SexMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* identify as an ethnic/racial minority with HIV
* identify as gay, same-gender-loving, or MSM
* able to read and understand English
* access to a computer capable of downloading and running the VE software
* no medical history of serious cardiovascular or cognitive complications
Exclusion Criteria:
Anything outside of inclusion parameters, including history of:
* myocardial infarction (MI)
* congestive heart failure (CHF)
* coronary artery bypass graft (CABG)
* cerebral vascular accident (CVA)
* cognitive impairment
What they're measuring
1
Acceptability/Feasibility {change over 3 timepoints}